Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $61.08MP/E –Yield –
Earnings
Nuo Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q2 FY2026
$1.77M
EPS, Q2 FY2026
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Nuo Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 17, 2026before the open | $1.77M | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 14, 2026after the close | $1.30M | – | -$0.01 | Release |
| Q3 FY2015ended Sep 30, 2015 | Nov 13, 2015after the close | – | – | – | Filing |
| Q2 FY2015ended Jun 30, 2015 | Aug 13, 2015after the close | – | – | – | Filing |
| Q1 FY2015ended Mar 31, 2015 | May 14, 2015before the open | – | – | – | Filing |
| Q4 FY2014ended Dec 31, 2014 | Mar 31, 2015after the close | – | – | – | Filing |
| Q4 FY2012ended Dec 31, 2012 | Feb 20, 2013before the open | – | – | – | Filing |
| Q2 FY2012ended Jun 30, 2012 | Jul 10, 2012after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Nuo Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Nuo Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Nuo Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
See a number that looks wrong?